nach oben

Erschienen in:

01.06.2013 | Original Article

Polymorphisms in the Selenoprotein S gene and subclinical cardiovascular disease in the Diabetes Heart Study

verfasst von: Amanda. J. Cox, Allison B. Lehtinen, Jianzhao Xu, Carl D. Langefeld, Barry I. Freedman, J. Jeffrey Carr, Donald W. Bowden

Erschienen in: Acta Diabetologica | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Selenoprotein S (SelS) has previously been associated with a range of inflammatory markers, particularly in the context of cardiovascular disease (CVD). The aim of this study was to examine the role of SELS genetic variants in risk for subclinical CVD and mortality in individuals with type 2 diabetes mellitus (T2DM). The association between 10 polymorphisms tagging SELS and coronary (CAC), carotid (CarCP) and abdominal aortic calcified plaque, carotid intima media thickness and other known CVD risk factors was examined in 1220 European Americans from the family-based Diabetes Heart Study. The strongest evidence of association for SELS SNPs was observed for CarCP; rs28665122 (5′ region; β = 0.329, p = 0.044), rs4965814 (intron 5; β = 0.329, p = 0.036), rs28628459 (3′ region; β = 0.331, p = 0.039) and rs7178239 (downstream; β = 0.375, p = 0.016) were all associated. In addition, rs12917258 (intron 5) was associated with CAC (β = −0.230, p = 0.032), and rs4965814, rs28628459 and rs9806366 were all associated with self-reported history of prior CVD (p = 0.020–0.043). These results suggest a potential role for the SELS region in the development subclinical CVD in this sample enriched for T2DM. Further understanding the mechanisms underpinning these relationships may prove important in predicting and managing CVD complications in T2DM.

Nur mit Berechtigung zugänglich

American Heart Association (2010) Heart disease and stroke statistics–2010 update at-a-glance. American Heart Association

Centers for Disease Control and Prevention (2009) Diabetes data and trends. Department of Health and Human Services

Lu J, Holmgren A (2009) Selenoproteins. J Biol Chem 284(2):723–727PubMedCrossRef

Hesketh J (2008) Nutrigenomics and selenium: gene expression patterns, physiological targets, and genetics. Annu Rev Nutr 28:157–177PubMedCrossRef

Alanne M, Kristiansson K, Auro K, Silander K, Kuulasmaa K, Peltonen L, Salomaa V, Perola M (2007) Variation in the selenoprotein S gene locus is associated with coronary heart disease and ischemic stroke in two independent finnish cohorts. Hum Genet 122(3–4):355–365PubMedCrossRef

Olsson M, Olsson B, Jacobson P, Thelle DS, Bjorkegren J, Walley A, Froguel P, Carlsson LM, Sjoholm K (2011) Expression of the selenoprotein S (SELS) gene in subcutaneous adipose tissue and SELS genotype are associated with metabolic risk factors. Metabolism 60(1):114–120PubMedCrossRef

Martinez A, Santiago JL, Varade J, Marquez A, Lamas JR, Mendoza JL, de la Calle H, Diaz-Rubio M, de la Concha EG, Fernandez-Gutierrez B, Urcelay E (2008) Polymorphisms in the selenoprotein S gene: lack of association with autoimmune inflammatory diseases. BMC Genomics 9:329PubMedCrossRef

Bellinger FP, Raman AV, Reeves MA, Berry MJ (2009) Regulation and function of selenoproteins in human disease. Biochem J 422(1):11–22PubMedCrossRef

Zhang K, Kaufman RJ (2008) From endoplasmic-reticulum stress to the inflammatory response. Nature 454(7203):455–462PubMedCrossRef

10.

Schroder M (2008) Endoplasmic reticulum stress responses. Cell Mol Life Sci 65(6):862–894PubMedCrossRef

11.

Hotamisligil GS (2010) Endoplasmic reticulum stress and atherosclerosis. Nat Med 16(4):396–399PubMedCrossRef

12.

Hotamisligil GS (2008) Inflammation and endoplasmic reticulum stress in obesity and diabetes. Int J Obes (Lond) 32(Suppl 7):S52–S54CrossRef

13.

Schroder M, Sutcliffe L (2010) Consequences of stress in the secretary pathway: the ER stress response and its role in the metabolic syndrome. Methods Mol Biol 648:43–62PubMedCrossRef

14.

Gao Y, Hannan NR, Wanyonyi S, Konstantopolous N, Pagnon J, Feng HC, Jowett JB, Kim KH, Walder K, Collier GR (2006) Activation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HEPG2 cells. Cytokine 33(5):246–251PubMedCrossRef

15.

Curran JE, Jowett JB, Elliott KS, Gao Y, Gluschenko K, Wang J, Abel Azim DM, Cai G, Mahaney MC, Comuzzie AG, Dyer TD, Walder KR, Zimmet P, MacCluer JW, Collier GR, Kissebah AH, Blangero J (2005) Genetic variation in selenoprotein S influences inflammatory response. Nat Genet 37(11):1234–1241PubMedCrossRef

16.

Bos SD, Kloppenburg M, Suchiman E, van Beelen E, Slagboom PE, Meulenbelt I (2009) The role of plasma cytokine levels, CRP and selenoprotein S gene variation in OA. Osteoarthr Cartil 17(5):621–626PubMedCrossRef

17.

Budoff MJ (2003) Atherosclerosis imaging and calcified plaque: coronary artery disease risk assessment. Prog Cardiovasc Dis 46(2):135–148PubMedCrossRef

18.

Sipila K, Kahonen M, Salomaa V, Paivansalo M, Karanko H, Varpula M, Jula A, Kaaja R, Kesaniemi YA, Reunanen A, Moilanen L (2012) Carotid artery intima-media thickness and elasticity in relation to glucose tolerance. Acta Diabetol 49(3):215–223PubMedCrossRef

19.

Miyamoto M, Kotani K, Okada K, Fujii Y, Konno K, Ishibashi S, Taniguchi N (2012) The correlation of common carotid arterial diameter with atherosclerosis and diabetic retinopathy in patients with type 2 diabetes mellitus. Acta Diabetol 49(1):63–68PubMedCrossRef

20.

Bowden DW, Cox AJ, Freedman BI, Hugenschmidt CE, Wagenknecht LE, Herrington D, Agarwal S, Register TD, Maldjian JA, Ng MC-Y, Hsu F-C, Langefeld CD, Williamson JD, Carr JJ (2010) Review of the diabetes heart study (DHS) family of studies: a comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its complications. Rev Diabet Stud 7(3):188–201PubMed

21.

Bowden DW, Lehtinen AB, Ziegler JT, Rudock ME, Xu J, Wagenknecht LE, Herrington DM, Rich SS, Freedman BI, Carr JJ, Langefeld CD (2008) Genetic epidemiology of subclinical cardiovascular disease in the diabetes heart study. Ann Hum Genet 72(Pt 5):598–610PubMedCrossRef

22.

Wagenknecht LE, Bowden DW, Carr JJ, Langefeld CD, Freedman BI, Rich SS (2001) Familial aggregation of coronary artery calcium in families with type 2 diabetes. Diabetes 50(4):861–866PubMedCrossRef

23.

Bowden DW, Rudock M, Ziegler J, Lehtinen AB, Xu J, Wagenknecht LE, Herrington D, Rich SS, Freedman BI, Carr JJ, Langefeld CD (2006) Coincident linkage of type 2 diabetes, metabolic syndrome, and measures of cardiovascular disease in a genome scan of the diabetes heart study. Diabetes 55(7):1985–1994PubMedCrossRef

24.

Lange LA, Bowden DW, Langefeld CD, Wagenknecht LE, Carr JJ, Rich SS, Riley WA, Freedman BI (2002) Heritability of carotid artery intima-medial thickness in type 2 diabetes. Stroke 33(7):1876–1881PubMedCrossRef

25.

Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285(19):2486–2497CrossRef

26.

Carr JJ, Crouse JR, Goff DC Jr, D’Agostino RB Jr, Peterson NP, Burke GL (2000) Evaluation of subsecond gated helical CT for quantification of coronary artery calcium and comparison with electron beam CT. AJR Am J Roentgenol 174(4):915–921PubMedCrossRef

27.

Carr JJ, Nelson JC, Wong ND, McNitt-Gray M, Arad Y, Jacobs DR Jr, Sidney S, Bild DE, Williams OD, Detrano RC (2005) Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of multi-ethnic study of atherosclerosis (MESA) and coronary artery risk development in young adults (CARDIA) study. Radiology 234(1):35–43PubMedCrossRef

28.

Hyrenbach S, Pezzini A, del Zotto E, Giossi A, Lichy C, Kloss M, Werner I, Padovani A, Brandt T, Grond-Ginsbach C (2007) No association of the -105 promoter polymorphism of the selenoprotein S encoding gene SEPS1 with cerebrovascular disease. Eur J Neurol 14(10):1173–1175PubMedCrossRef

29.

Buetow KH, Edmonson M, MacDonald R, Clifford R, Yip P, Kelley J, Little DP, Strausberg R, Koester H, Cantor CR, Braun A (2001) High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci USA 98(2):581–584PubMedCrossRef

30.

Almasy L, Blangero J (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62(5):1198–1211PubMedCrossRef

31.

Cambridge B, Cina SJ (2010) The accuracy of death certificate completion in a suburban community. Am J Forensic Med Pathol 31(3):232–235PubMedCrossRef

32.

Sington JD, Cottrell BJ (2002) Analysis of the sensitivity of death certificates in 440 hospital deaths: a comparison with necropsy findings. J Clin Pathol 55(7):499–502PubMedCrossRef

33.

Gao Y, Feng HC, Walder K, Bolton K, Sunderland T, Bishara N, Quick M, Kantham L, Collier GR (2004) Regulation of the selenoprotein SELS by glucose deprivation and endoplasmic reticulum stress—SELS is a novel glucose-regulated protein. FEBS Lett 563(1–3):185–190PubMedCrossRef

Titel: Polymorphisms in the Selenoprotein S gene and subclinical cardiovascular disease in the Diabetes Heart Study
verfasst von: Amanda. J. Cox
Allison B. Lehtinen
Jianzhao Xu
Carl D. Langefeld
Barry I. Freedman
J. Jeffrey Carr
Donald W. Bowden
Publikationsdatum: 01.06.2013
Verlag: Springer Milan
Erschienen in: Acta Diabetologica / Ausgabe 3/2013
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-012-0440-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2013

Systemic exposure to Pseudomonal bacteria: a potential link between type 1 diabetes and chronic inflammation

Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes

A SNP in G6PC2 predicts insulin secretion in type 1 diabetes

PPARG2 Pro12Ala and ADAMTS9 rs4607103 as “insulin resistance loci” and “insulin secretion loci” in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4

Achieving glycemic control in patients with type 2 diabetes and renal impairment